12/26/24
Wills Eye Hospital is part of a multi-site clinical trial to explore the potential benefit of repetitive transorbital alternating current stimulation (rtACS) on neuronal morphology and physiology. This collaborative study is expected to provide valuable insight into rtACS as a potential treatment for those with vision loss from glaucoma and various optic neuropathies.
Read the article in Ophthalmology Times.